Separating the effects of early and later life body mass index on liver diseases: A Mendelian randomization study

被引:0
作者
Zhou, Feixiang [1 ]
Liu, Xia [2 ]
Chang, Canyan [3 ]
Liu, Jing [4 ]
He, Simin [1 ]
Yan, Yan [1 ]
机构
[1] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410078, Hunan, Peoples R China
[2] PetroChina Changqing Oilfield Co, Oil Prod Plant 6, Xian, Shaanxi, Peoples R China
[3] PetroChina Changqing Oilfield Co, Oil Prod Plant 5, Xian, Shaanxi, Peoples R China
[4] PetroChina Changqing Oilfield Co, Oil Prod Plant 12, Xian, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Mendelian randomization; Body mass index; Non-alcoholic fatty liver disease; Cirrhosis; Hepatocellular carcinoma; OBESITY; CHILDHOOD; LEPTIN; RISK; ADIPONECTIN; METAANALYSIS; ASSOCIATION; INSIGHTS;
D O I
10.1016/j.clinre.2024.102352
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aim: The independent effects of childhood and adult body mass index (BMI) on non-alcoholic fatty liver disease (NAFLD), cirrhosis, and hepatocellular carcinoma (HCC) are lacking assessment. We aimed to separate the effects of childhood and adult BMI on NAFLD, cirrhosis, and HCC. Methods: Genetic variants associated with childhood and adult BMI were selected as instrumental variables. Twosample univariable and multivariable MR estimated the total and direct effect of childhood and adult BMI on NAFLD, cirrhosis, and HCC. Results: Genetically predicted each 1-SD increased childhood BMI (OR = 1.30, 95 % CI = 1.12 to 1.51, P = 0.001) and adult BMI (OR = 1.57 95 % CI = 1.33 to 1.84, P = 5.49E-08) was associated with an increased risk of NAFLD. The association between childhood BMI (OR = 0.97, 95 % CI = 0.77 to 1.24, P = 0.825) and NAFLD did not remain significant after adjusting for adult BMI (OR =1.64, 95 % CI =1.23 to 2.20, P = 0.001). The direct effects of childhood and adult BMI on cirrhosis and HCC were insignificant after considering their relationship. Conclusion: Maintaining a normal BMI in adulthood significantly reduces the adverse effect of a higher childhood BMI on NAFLD. Further investigation is required to clarify the presence of this effect in cirrhosis and HCC.
引用
收藏
页数:8
相关论文
共 30 条
  • [1] Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
    Anstee, Quentin M.
    Darlay, Rebecca
    Cockell, Simon
    Meroni, Marica
    Govaere, Olivier
    Tiniakos, Dina
    Burt, Alastair D.
    Bedossa, Pierre
    Palmer, Jeremy
    Liu, Yang-Lin
    Aithal, Guruprasad P.
    Allison, Michael
    Yki-Jarvinen, Hannele
    Vacca, Michele
    Dufour, Jean-Francois
    Invernizzi, Pietro
    Prati, Daniele
    Ekstedt, Mattias
    Kechagias, Stergios
    Francque, Sven
    Petta, Salvatore
    Bugianesi, Elisabetta
    Clement, Karine
    Ratziu, Vlad
    Schattenberg, Joern M.
    Valenti, Luca
    Day, Christopher P.
    Cordell, Heather J.
    Daly, Ann K.
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (03) : 505 - 515
  • [2] Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents
    Ayonrinde, Oyekoya T.
    Olynyk, John K.
    Marsh, Julie A.
    Beilin, Lawrence J.
    Mori, Trevor A.
    Oddy, Wendy H.
    Adams, Leon A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 163 - 171
  • [3] Body mass index in childhood and adult risk of primary liver cancer
    Berentzen, Tina Landsvig
    Gamborg, Michael
    Holst, Claus
    Sorensen, Thorkild I. A.
    Baker, Jennifer L.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (02) : 325 - 330
  • [4] Adiponectin, a key adipokine in obesity related liver diseases
    Buechler, Christa
    Wanninger, Josef
    Neumeier, Markus
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (23) : 2801 - 2811
  • [5] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357
  • [6] Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood
    Cuthbertson, Daniel J.
    Brown, Emily
    Koskinen, Juha
    Magnussen, Costan G.
    Hutri-Kahonen, Nina
    Sabin, Matthew
    Tossavainen, Paeivi
    Jokinen, Eero
    Laitinen, Tomi
    Viikari, Jorma
    Raitakari, Olli T.
    Juonala, Markus
    [J]. LIVER INTERNATIONAL, 2019, 39 (06) : 1147 - 1154
  • [7] Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis
    Dattaroy, Diptadip
    Pourhoseini, Sahar
    Das, Suvarthi
    Alhasson, Firas
    Seth, Ratanesh Kumar
    Nagarkatti, Mitzi
    Michelotti, Gregory A.
    Diehl, Anna Mae
    Chatterjee, Saurabh
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2015, 308 (04): : G298 - G312
  • [8] EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
    Marchesini G.
    Day C.P.
    Dufour J.-F.
    Canbay A.
    Nobili V.
    Ratziu V.
    Tilg H.
    Roden M.
    Gastaldelli A.
    Yki-Järvinen H.
    Schick F.
    Vettor R.
    Frühbeck G.
    Mathus-Vliegen L.
    [J]. OBESITY FACTS, 2016, 9 (02) : 65 - 90
  • [9] Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
    Ghodsian, Nooshin
    Abner, Erik
    Emdin, Connor A.
    Gobeil, Emilie
    Taba, Nele
    Haas, Mary E.
    Perrot, Nicolas
    Manikpurage, Hasanga D.
    Gagnon, Eloi
    Bourgault, Jerome
    St-Amand, Alexis
    Couture, Christian
    Mitchell, Patricia L.
    Bosse, Yohan
    Mathieu, Patrick
    Vohl, Marie-Claude
    Tchernof, Andre
    Theriault, Sebastien
    Khera, Amit V.
    Esko, Tonu
    Arsenault, Benoit J.
    [J]. CELL REPORTS MEDICINE, 2021, 2 (11)
  • [10] Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
    Jarvis, Helen
    Craig, Dawn
    Barker, Robert
    Spiers, Gemma
    Stow, Daniel
    Anstee, Quentin M.
    Hanratty, Barbara
    [J]. PLOS MEDICINE, 2020, 17 (04)